Literature DB >> 4296276

Sero-epidemiologic studies of Sendai virus infection on Taiwan.

F H Tai, S Chiu, C C Ma.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 4296276

Source DB:  PubMed          Journal:  Taiwan Yi Xue Hui Za Zhi        ISSN: 0371-7682


× No keyword cloud information.
  3 in total

1.  Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.

Authors:  R Sealy; B G Jones; S L Surman; J L Hurwitz
Journal:  Vaccine       Date:  2010-08-01       Impact factor: 3.641

2.  Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Authors:  Elisabeth Adderson; Kristen Branum; Robert E Sealy; Bart G Jones; Sherri L Surman; Rhiannon Penkert; Pamela Freiden; Karen S Slobod; Aditya H Gaur; Randall T Hayden; Kim Allison; Nanna Howlett; Jill Utech; Jim Allay; James Knight; Susan Sleep; Michael M Meagher; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2014-12-31

3.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.